VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial
British Journal of Biomedical Science · 27.07.2026 · 83
DOI: 10.3389/bjbs.2026.16993 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Biomedical Science, online erschienen am 27.07.2026. Verfasst von Chiara Amoroso und 20 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Fatigue, COVID-19, Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Long COVID is frequently characterized by persistent fatigue and impaired quality of life. Increasing evidence suggests that gut microbiota dysbiosis and immune dysregulation may contribute to symptom persistence. We evaluated the effects of the probiotic formulation VSL#3® in patients with long COVID.
Methods
In this randomized, double-blind, placebo-controlled trial (ClinicalTrials.gov identifier: NCT05874089), patients with long COVID and clinically relevant fatigue received VSL#3® or placebo for 4 weeks. The primary endpoint was fatigue improvement assessed by the Chalder Fatigue Scale (CFS). Secondary and exploratory analyses included patient-reported outcomes, gut microbiota profiling, immune phenotyping, cytokine analyses, and targeted metabolomics.
Results
Forty-eight patients completed the study (placebo n = 25; VSL#3® n = 23). VSL#3® supplementation significantly improved fatigue compared with placebo, with a greater reduction in CFS score (24.24% vs. 6.06%; p = 0.037) and a higher proportion of responders (68% vs. 35.7%; p = 0.019). Clinical benefit persisted after treatment discontinuation and was accompanied by improvements in selected quality-of-life and gastrointestinal symptom domains. VSL#3® supplementation was associated with selective enrichment of health-associated bacterial taxa, including Bifidobacterium , Lactobacillus , Ruminococcus , and Coprococcus , together with modulation of inflammatory and immune-related pathways. Exploratory multi-omic analyses identified coordinated associations among microbiota-derived metabolites, immune markers, and clinical outcomes.
Conclusion
VSL#3® supplementation improved fatigue and selected clinical outcomes in patients with long COVID and was associated with coordinated microbiota and immune changes. These findings support further investigation of microbiota-targeted interventions in long COVID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
- Department of Pharmacy, University of Salerno, Fisciano, Italy.
- Infectious Disease Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
- Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy.
Zitieren
APA
Amoroso, C., Marinoni, B., Maragno, P., Rimondi, A., Bottaro, F., Ciafardini, C., Muià, M., Honcharyuk, I., Noviello, D., Caridi, B., Sommella, E. M., Bandera, A., Gori, A., Mantero, M., Blasi, F., Ferrucci, R., Priori, A., Strati, F., Vecchi, M., …, & Caprioli, F. (2026). VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial. British Journal of Biomedical Science, 83. https://doi.org/10.3389/bjbs.2026.16993
Vancouver
Amoroso C, Marinoni B, Maragno P, Rimondi A, Bottaro F, Ciafardini C, et al. VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial. British Journal of Biomedical Science. 2026;83. doi:10.3389/bjbs.2026.16993
BibTeX
@article{Amoroso2026,
author = {Amoroso, Chiara and Marinoni, Beatrice and Maragno, Paola and Rimondi, Alessandro and Bottaro, Federico and Ciafardini, Clorinda and Muià, Martina and Honcharyuk, Ivanna and Noviello, Daniele and Caridi, Bruna and Sommella, Eduardo Maria and Bandera, Alessandra and Gori, Andrea and Mantero, Marco and Blasi, Francesco and Ferrucci, Roberta and Priori, Alberto and Strati, Francesco and Vecchi, Maurizio and Facciotti, Federica and Caprioli, Flavio},
title = {VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial},
journal = {British Journal of Biomedical Science},
year = {2026},
volume = {83},
doi = {10.3389/bjbs.2026.16993}
}
EUVIMED